Sustainable Practices in Pharmaceutical Manufacturing: A Path toward Green Pharmacy

The pharmaceutical industry has a profound impact on environmental sustainability, stemming from its resource-intensive manufacturing and the disposal of hazardous chemical waste (Gibson et al., 2021). This dissertation examines sustainable practices in pharmaceutical manufacturing, focusing on strategies to transition towards “green pharmacy.†By addressing challenges such as resource depletion, pollution, and inefficiencies, the study highlights innovative solutions, including the principles of green chemistry, waste reduction methods, energy-efficient technologies, and lifecycle assessments (Anastas & Warner, 1998; Clark et al., 2019). Regulatory frameworks and international guidelines, such as those by the EPA and ICH, are discussed to underscore their role in fostering sustainability (Constable et al., 2021; ICH, 2022). Furthermore, the study explores successful case studies from leading pharmaceutical companies adopting renewable energy and solvent recovery systems (Horváth et al., 2004). While significant progress has been made, challenges such as high initial investment costs, regulatory complexities, and limited awareness persist. Despite these, opportunities abound in biopharmaceutical innovations, stakeholder collaborations, and the rising demand for eco-friendly products. This dissertation concludes by advocating for policy reforms, collaborative industry efforts, increased R&D funding, and public awareness campaigns to align the pharmaceutical sector with global sustainability goals (Sheldon, 2017; Kümmerer et al., 2020). The integration of these measures can mitigate environmental harm, promote public health, and ensure the long-term viability of the industry.